Go Deep
ProKidney Corp.
ProKidney Corp. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -16,771 | -2.9 | -0.71 | 0.02 | 149.52 |
| Oct 2026 | -16,604 | -2.7 | -0.66 | 0.02 | 139.57 |
| Oct 2026 | -16,580 | -2.9 | -0.66 | 0.02 | 138.17 |
| Oct 2026 | -16,371 | -2.4 | -0.60 | 0.02 | 125.97 |
| Oct 2026 | -16,480 | -2.5 | -0.63 | 0.02 | 132.27 |
| Oct 2026 | -16,555 | -2.6 | -0.65 | 0.02 | 136.54 |
| Oct 2026 | -16,555 | -2.6 | -0.65 | 0.02 | 136.20 |
| Oct 2026 | -16,538 | -2.6 | -0.65 | 0.02 | 134.98 |
| Oct 2026 | -16,505 | -2.6 | -0.64 | 0.02 | 133.64 |
ProKidney Corp. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 150,000.0 | 226,000.0 | 225,000.0 | 217,000.0 |
| Net Profit | -28,422,000.0 | -20,037,000.0 | -19,231,000.0 | -16,469,000.0 |
| EPS | -0.1 | -0.1 | — | -0.1 |
ProKidney Corp. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 893,000.0 | 76,000.0 | 0.0 | 0.0 |
| Net Profit | -68,986,000.0 | -61,186,000.0 | -35,468,000.0 | -108,032,000.0 |
| EPS | -0.5 | -0.6 | -0.6 | -0.2 |
ProKidney Corp. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 335,574,000.0 | 441,073,000.0 | 420,552,000.0 | 517,996,000.0 | — |
| Total Liabilities | 34,781,000.0 | 39,436,000.0 | 29,216,000.0 | 13,057,000.0 | — |
| Total Equity | -1,011,197,000.0 | -994,954,000.0 | -1,103,396,000.0 | -1,096,616,000.0 | — |
Owes vs Owns
ProKidney Corp. owed $0.11 for every $1 it owned in Jun 2026, up from $0.03 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.11× | 0.10× | 0.09× | 0.07× | 0.03× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
ProKidney Corp. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 80.5%Fixed assets (tangible) 16.4%Other assets 2.8%
How it's funded — Dec 2025
Long-term debt 0.9%Other liabilities 8.9%Shareholders' equity 89.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 270.0 | 358.3 | 362.9 | 490.3 |
| Receivables | 1.1 | 2.4 | 1.4 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 54.9 | 45.2 | 46.4 | 13.1 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 9.5 | 35.1 | 9.8 | 14.5 |
| Liabilities & equity | ||||
| Short-term debt | 1.1 | 0.8 | 0.8 | 0.5 |
| Long-term debt | 3.0 | 2.5 | 3.6 | 1.9 |
| Payables | 0.9 | 3.6 | 5.1 | 3.0 |
| Other liabilities | 29.8 | 32.6 | 19.7 | 7.6 |
| Shareholders' equity | 300.8 | 401.6 | 391.3 | 504.9 |
| Net tangible assets | -1,011.2 | -995.0 | -1,103.4 | -1,096.8 |
ProKidney Corp. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -120,117,000.0 | -126,351,000.0 | -90,069,000.0 | -77,089,000.0 | — |
| Investing Activities | 103,965,000.0 | 20,414,000.0 | -329,983,000.0 | -1,738,000.0 | — |
| Financing Activities | 25,569,000.0 | 144,408,000.0 | -9,551,000.0 | 548,521,000.0 | — |